| Date | Form | Description | Docs | XBRL | Pages |
| 01/12/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/10/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/07/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/04/22 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
27 | |
| 01/04/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
63 |
| 12/09/21 | 8-K | Current report filing |
|
|
2 |
| 11/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/01/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/01/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
Read More...Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Read More...Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy
Read More...